West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
6WST : West Pharmaceutical Servs's Options Frenzy: What...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
West Pharma upgraded at Deutsche Bank despite earnings led selloff
West Pharmaceutical Services (WST) stock was upgraded to Buy at Deutsche Bank due to an attractive entry point post-selloff. Read more here.
Deutsche Bank upgrades West Pharmaceutical to Buy after selloff
Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
Why West Pharmaceutical Services, Inc. (WST) Went Down on Thursday
We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...
Is WST Stock Undervalued At $200?
At its present level of around $200, WST stock is trading at just 5.1x trailing revenue, compared to its five-year average ...
West Pharma (WST) Stock Leads S&P 500 Rout with 38% Slump
West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...
West Pharmaceutical targets 2-3% organic sales growth for 2025, highlights GLP-1 market expansion
Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.